News | Stethoscopes | October 26, 2018

Eko, Mayo Clinic Collaborating on AI-Based Heart Disease Detection

Eko’s software and smart digital stethoscope combined with Mayo’s vast data and tech aims to help physicians with earlier detection of life-threatening conditions

Eko, Mayo Clinic Collaborating on AI-Based Heart Disease Detection

October 26, 2018 — Eko, creators of a machine learning-based heart and lung monitoring platform, announced a collaboration with Mayo Clinic to develop a data-driven technology to help physicians detect potentially dangerous heart diseases that may otherwise be missed. The two entities will work together to develop and commercialize a machine learning-based algorithm with a smart digital stethoscope that screens patients for the presence of a low ejection fraction. Once identified, evidence-based treatments are available that prolong life and reduce the risk of symptoms.

The technology leverages the Mayo Clinic’s vast cardiovascular database and their expertise in medical artificial intelligence (AI) and heart disease screening, and combines it with Eko’s cardiac monitoring platform. Traditionally, ejection fraction is measured by imaging techniques such as echocardiography, which is a powerful but expensive and time-consuming test that is less accessible to most people in North America and around the world than a doctor with a stethoscope. With this algorithm, Eko can help screen patients in seconds in the doctor’s office. Because the Eko tool can be used by any healthcare provider, it may detect heart function abnormalities earlier and in patients who might not otherwise be screened for heart disease.

“With this collaboration we hope to transform the stethoscope in the pocket of every physician and nurse from a hand tool to a power tool,” said Paul Friedman, M.D., chair of cardiovascular medicine at Mayo Clinic in Rochester, Minn. “The community practitioner performing high school sports physicals and the surgeon about to operate may be able to seamlessly tap the knowledge of an experienced cardiologist to determine if a weak heart pump is present simply by putting a stethoscope on a person’s chest for a few seconds.”

Eko aims to gain U.S. Food and Drug Administration (FDA) approval for the technology after running clinical studies with Mayo Clinic to demonstrate the safety and effectiveness of the algorithms for in-clinic screening.

Mayo Clinic and Friedman have financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

For more information: www.ekodevices.com


Related Content

News | Artificial Intelligence

September 21, 2023 — Heart Test Laboratories, Inc., an AI-powered medical technology company focused on transforming ...

Home September 21, 2023
Home
News | Artificial Intelligence

September 7, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced that ...

Home September 07, 2023
Home
News | Artificial Intelligence

September 7, 2023 — Vektor Medical, developer of the only technology to accurately map arrhythmias using just 12-lead ...

Home September 07, 2023
Home
News | Artificial Intelligence

September 6, 2023 — GE HealthCare and Mass General Brigham have announced, as part of its initial collaboration, the co ...

Home September 06, 2023
Home
News | Artificial Intelligence

August 24, 2023 —Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical ...

Home August 24, 2023
Home
News | Artificial Intelligence

August 23, 2023 — Medtronic is announcing the first patient treated in a global pilot program in collaboration with ...

Home August 23, 2023
Home
News | Artificial Intelligence

August 17, 2023 — Artificial intelligence (AI) is capturing the public imagination as the pace of innovation accelerates ...

Home August 18, 2023
Home
News | Artificial Intelligence

August 15, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced it has ...

Home August 15, 2023
Home
News | Artificial Intelligence

August 10, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a ...

Home August 10, 2023
Home
News | Artificial Intelligence

August 10, 2023 — Cleerly, an artificial intelligence (AI) digital healthcare company, recently announced it was named ...

Home August 10, 2023
Home
Subscribe Now